Literature DB >> 23587593

Identification of a cystic fibrosis mutation W19X in Tunisia.

Monia Boudaya1, Sondess Hadj Fredj, Hajer Siala, Amina Bibi, Taieb Messaoud.   

Abstract

Cystic fibrosis (CF) is a common and serious condition with autosomal recessive inheritance. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). The frequencies of mutations vary according to the ethnic origin of populations. We describe in this study a patient with cystic fibrosis. She was homozygous for a new nonsense mutation identified for the first time in Tunisia: W19X, which expected to cause significant morbidity. This mutation appears to be specific to Tunisian population, although, it has identified only in CF Tunisian patients. The information provided by our study contributes to defining the molecular spectrum of CF in Tunisia, to improve genetic testing and prenatal diagnosis.

Entities:  

Keywords:  CF mutation; Tunisian patient; W19X; cystic fibrosis

Mesh:

Substances:

Year:  2013        PMID: 23587593     DOI: 10.1684/abc.2013.0790

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  2 in total

1.  Angiotensin-converting enzyme insertion/deletion gene polymorphism in cystic fibrosis patients.

Authors:  Sabrine Oueslati; Sondess Hadj Fredj; Hajer Siala; Amina Bibi; Hajer Aloulou; Lamia Boughamoura; Khadija Boussetta; Sihem Barsaoui Barsaoui; Taieb Messaoud
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

2.  Genetics and genomic medicine in Tunisia.

Authors:  Houda Elloumi-Zghal; Habiba Chaabouni Bouhamed
Journal:  Mol Genet Genomic Med       Date:  2018-03       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.